CENCORA, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
CENCORA, INC. (COR) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $655.99 million for the 12-month period ending 2025-09-30, per its 8-K filed 2026-02-10.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-02-10
- CENCORA, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-09-30 was $11.01M.
- CENCORA, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-06-30 was $18.23M.
- CENCORA, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-03-31 was $26.62M.
- CENCORA, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-12-31 was $5.92M.
- CENCORA, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $179.21M, a 76.75% decline from fiscal 2021.
- CENCORA, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $770.86M, a 1147.77% increase from fiscal 2020.
- CENCORA, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2020 was $61.78M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-09-30 | $655.99M 8-K · filed 2026-02-10 | |||
| 2024-09-30 | $305.88M 8-K · filed 2026-02-10 | |||
| 2023-09-30 | $271.10M 8-K · filed 2026-02-10 | |||
| 2022-09-30 | $179.21M 10-K · filed 2024-11-26 | |||
| 2021-09-30 | $770.86M 10-K · filed 2023-11-21 | |||
| 2020-09-30 | $11.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $29.24M derived: sum of 2 quarters · filed 2022-11-22 | $55.86M derived: sum of 3 quarters · filed 2022-11-22 | $61.78M 10-K · filed 2022-11-22 |
| 2020-06-30 | $18.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | $44.85M derived: sum of 2 quarters · filed 2020-08-05 | $50.77M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $26.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $32.54M 10-Q · filed 2020-05-07 | ||
| 2019-12-31 | $5.92M 10-Q · filed 2020-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |